Actavis Plc and Allergan Inc. Chief Executive Officers Discuss Merger

David Pyott, chief executive officer of Allergan Inc., speaks during a Bloomberg Television interview in New York, U.S., on Monday, Nov. 24, 2014. Actavis Plc outspent rival Valeant Pharmaceuticals International Inc. in the $64 billion contest for Botox-maker Allergan Inc. Photographer: Scott Eells/Bloomberg via Getty Images
David Pyott, chief executive officer of Allergan Inc., speaks during a Bloomberg Television interview in New York, U.S., on Monday, Nov. 24, 2014. Actavis Plc outspent rival Valeant Pharmaceuticals International Inc. in the $64 billion contest for Botox-maker Allergan Inc. Photographer: Scott Eells/Bloomberg via Getty Images
Actavis Plc and Allergan Inc. Chief Executive Officers Discuss Merger
COMPRAR UMA LICENÇA
Como posso utilizar esta imagem?
475,00 €
EUR

DETALHES

Restrições:
Contacte o representante local para todos os usos comerciais ou promocionais.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial #:
459519496
Coleção:
Bloomberg
Data da criação:
24 de novembro de 2014
Data do upload:
Tipo de licença:
Rights-managed
Inf. sobre autorização:
Não tem autorização. Mais informações
Fonte:
Bloomberg
Nome do objeto:
ACTAVIS ALLERGAN DEAL
Tamanho máx.:
3960 x 2640 px (33,53 x 22,35 cm) - 300 dpi - 649 KB